ArticleCardiovascular therapeutics2022

Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study.

Dennis Steenhuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.